Leuprolide Recruiting Phase 2 Trials for Metastasis Prostate Adenocarcinoma / Hormone Sensitive Prostate Cancer / Adenocarcinoma, Prostate Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04126070Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors
NCT03361735Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer